AVIR
Atea Pharmaceuticals Inc
5.20$
-2.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.2% | -7.0% | -7.7% | -3.8% | -5.4% | -5.3% | -11.0% | -12.4% | -8.1% | -15.3% | -13.0% | |
| – | -2.1% | -7.1% | -7.7% | -3.8% | -5.0% | -6.2% | -11.1% | -12.8% | -7.5% | -15.4% | -13.1% | |
| – | +4.3% | +11.9% | +51.3% | -59.5% | -34.3% | +84.5% | -26.5% | -11.8% | +23.7% | -17.1% | -3.5% | |
| – | -2.9% | -6.3% | -7.3% | -3.9% | -5.8% | -6.4% | -10.7% | -13.3% | -8.3% | -15.2% | -14.3% | |
| – | +51.0% | +22.3% | -30.3% | -4.4% | -20.5% | +11.9% | -5.9% | 0.0% | +46.4% | -16.1% | -15.7% | |
| – | +71.4% | +27.6% | -35.6% | -5.4% | -26.1% | +16.9% | -7.5% | +0.3% | +97.2% | -16.1% | -15.7% | |
| – | +1.3% | +1.2% | +1.4% | +1.3% | +1.3% | +1.4% | +1.2% | +1.3% | +1.3% | -24.8% | -33.1% | |
| – | +976.5% | +397.1% | -74.1% | +5.8% | -22.9% | +65.7% | +19.7% | -60.3% | +268.3% | -27.0% | +6.5% | |
| – | -4.6% | -9.2% | -5.5% | -3.8% | -4.3% | -6.3% | -11.4% | -13.3% | -12.8% | -15.1% | -12.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.6% | +0.4% | +0.2% | +0.0% | +0.8% | -1.7% | -5.6% | -1.2% | +1.4% | +1.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.